You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pd-0325901

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

KRAS Mutant NSCLC, Solid Tumors Trial in Boston (Palbociclib, PD-0325901)

Active, not recruiting
  • KRAS Mutant Non-Small Cell Lung Cancer
  • Solid Tumors
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 18, 2022

Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Oxford, United Kingdom
    Oxford University Hospital NHS Trust
Jun 14, 2021

Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN Trial in United States (PD-0325901)

Completed
Has Results
  • Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN
  • PD-0325901
  • Los Angeles, California
  • +10 more
Dec 17, 2018

Colorectal Cancer Trial in Amsterdam, Rotterdam, Utrecht (Dacomitinib, PD-0325901, Docetaxel)

Unknown status
  • Colorectal Cancer
  • Amsterdam, Netherlands
  • +2 more
Aug 24, 2018

Advanced Cancer Trial in Worldwide (PF-05212384, PD-0325901, irinotecan)

Terminated
Has Results
  • Advanced Cancer
  • Los Angeles, California
  • +17 more
Feb 13, 2018

Prior Treatment With PD-0325901 With Ongoing Clinical Response Trial in San Diego (PD-0325901)

No longer available
  • Prior Treatment With PD-0325901 With Ongoing Clinical Response
  • PD-0325901
  • San Diego, California
    Sharp Healthcare
Nov 24, 2014

Melanoma, Colonic Tumors, Breast Tumors Trial in United States (PD-0325901)

Terminated
  • Melanoma
  • +2 more
  • PD-0325901
  • Birmingham, Alabama
  • +16 more
Sep 11, 2013

NSCLC Trial in United States (PD-0325901)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • PD-0325901
  • Greenbrae, California
  • +13 more
Mar 16, 2009